Literature DB >> 23021780

Treatment strategies for atopic dermatitis: optimizing the available therapeutic options.

Amy S Paller1, Eric L Simpson, Lawrence F Eichenfield, Charles N Ellis, Anthony J Mancini.   

Abstract

Bathing and moisturization to control dryness, applications of topical anti-inflammatory agents (including corticosteroids and calcineurin inhibitors [TCIs]) to control flares, minimization of the risk for infection, and relief of pruritus are the cornerstones of effective therapy for atopic dermatitis. Education of parents and patients is crucial to enhance adherence. Strategies for reduced Staphylococcus aureus colonization may help control re-emergence of flares following cessation of antimicrobial treatment for infection; these include dilute bleach baths and minimizing the risk for contamination of topical agents. In severe, refractory cases, more aggressive therapy with systemic immunosuppressants may be considered, but appropriate laboratory testing must be included as part of patient monitoring during treatment. The value of adjuvant therapy with wet wraps to "cool down" particularly erythematous and pruritic flares is becoming increasingly recognized.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021780     DOI: 10.1016/j.sder.2012.07.004

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

1.  Prehydration is effective for rapid control of recalcitrant atopic dermatitis.

Authors:  Tamar Hajar; Jon M Hanifin; Susan J Tofte; Eric L Simpson
Journal:  Dermatitis       Date:  2014 Mar-Apr       Impact factor: 4.845

2.  IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation.

Authors:  Joshua B Wechsler; Chia-Lin Hsu; Paul J Bryce
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

3.  Irinotecan-Induced Skin Dryness Is Ameliorated By Orally Administered High-Dose Vitamin C In Mice.

Authors:  Kentaro Nakanishi; Kenji Goto; Kanako Kondo; Keiichi Hiramoto; Kazuya Ooi
Journal:  J Exp Pharmacol       Date:  2019-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.